Wei‐Kuang Yu

429 citations
19 papers · 281 indexed · h-index 9
Topics
Ocular Infections and Treatments (3 papers)IgG4-Related and Inflammatory Diseases (3 papers)Cancer and Skin Lesions (3 papers)
Partner nations
Taiwan

In The Last Decade

Wei‐Kuang Yu

17 papers receiving 279 citations

Peers

Wei‐Kuang Yu
Comparison fields: 5 of 70
  • Ophthalmology 104
  • Epidemiology 104
  • Molecular Biology 60
  • Rheumatology 55
  • Oncology 39
Replace Norman Saffra with:
Norman Saffra United States
Masaru Miyanaga Japan
Thekla Papadaki Greece
Giovanni Fogliato Italy
Deena Tajfirouz United States
Manisha Agarwal India
Dilen Parmar United Kingdom
Ecem Bostan Türkiye
Miguel Pedroza-Seres United States
Mehmet Baltaci Austria
Wei‐Kuang Yu relative to Norman Saffra United States Norman Saffra's profile →
Citations per field
00.5×4.7×
Norman Saffra · 1×
Citations per year

Countries citing papers authored by Wei‐Kuang Yu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Kuang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Kuang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Kuang Yu more than expected).

Fields of papers citing papers by Wei‐Kuang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Kuang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Kuang Yu. The network helps show where Wei‐Kuang Yu may publish in the future.

Co-authorship network of co-authors of Wei‐Kuang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Kuang Yu. A scholar is included among the top collaborators of Wei‐Kuang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Kuang Yu. Wei‐Kuang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 2
3 16
4 5
5 32
6 2
7 18
8 8
9 5
10 5
11 21
12 7
13 19
14 42
15 5
16 32
17 30
18 32
19
A new approach to measure women's breast volume using 3D body scan data
0

About Wei‐Kuang Yu

Wei‐Kuang Yu is a scholar working on Ophthalmology, Dermatology and Rheumatology, having authored 19 papers that have together received 281 indexed citations. Recurring topics across this work include Ocular Infections and Treatments (3 papers), IgG4-Related and Inflammatory Diseases (3 papers) and Cancer and Skin Lesions (3 papers). The work is most often cited by research in Ophthalmology (104 citations), Parasitology (24 citations) and Rheumatology (55 citations). Wei‐Kuang Yu has collaborated with scholars based in Taiwan. Frequent co-authors include Chieh‐Chih Tsai, Shu‐Ching Kao, Hui‐Chuan Kau, Catherine Jui-Ling Liu, Ching‐Fen Yang, Fenq-Lih Lee, Wen-Yih Liang, Ben‐Chang Shia, Te-Li Chen and Shui-Mei Lee. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Clinical Microbiology and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026